US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LIMOGES, UNIVERSITE DE LIMOGES on Nov. 3 for "Methods and kits for detecting liver dysfunction in a subject" (French Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,364, issued on Nov. 3, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LIMOGES (Limoges, France) and UNIVERSITE DE LIMOGES (Limoges, France).

"Methods and kits for detecting liver dysfunction in a subject" was invented by Souleiman El Balkhi (Limoges, France), Franck Saint Marcoux (Limoges, France) and Jean-Baptiste Woillard (Limoges, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Most chronic liver diseases are notoriously asymptomatic, until cirrhosis with clinical decompensation occurs. The use of early diagnosis strategies is vital to maintain patients...